Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study

被引:17
作者
Aareleid, Tiiu [1 ]
Zimmermann, Mari-Liis [2 ]
Baburin, Aleksei [1 ]
Innos, Kaire [1 ]
机构
[1] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Hiiu 42, EE-11619 Tallinn, Estonia
[2] Natl Inst Hlth Dev, Estonian Canc Registry, Hiiu 42, EE-11619 Tallinn, Estonia
来源
BMC CANCER | 2017年 / 17卷
关键词
Lung cancer; Population-based; Incidence; Mortality; Gender; Age; Histology; Time trends; Predictions; EDUCATIONAL INEQUALITIES; EUROPEAN COUNTRIES; DATA QUALITY; TIME TRENDS; SMOKING; WOMEN; ADENOCARCINOMA; MORTALITY; SURVIVAL; DEATH;
D O I
10.1186/s12885-017-3605-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lung cancer (LC) is the leading cause of cancer deaths in men and the second most frequent cause of cancer deaths in women in Estonia. The study aimed to analyze time trends in LC incidence and mortality in Estonia over the 30-year period, which included major social, economic and health care transition. The results are discussed in the context of changes in tobacco control and smoking prevalence. Long-term predictions of incidence and mortality are provided. Methods: Data for calculating the incidence and mortality rates in 1985-2014 were obtained from the nationwide population-based Estonian Cancer Registry and the Causes of Death Registry. Joinpoint regression was used to analyze trends and estimate annual percentage change (APC) with 95% confidence interval (CI). Nordpred model was used to project future incidence and mortality trends for 2015-2034. Results: Incidence peaked among men in 1991 and decreased thereafter (APC: -1.5, 95% CI: -1.8; -1.3). A decline was seen for all age groups, except age >= 75 years, and for all histological types, except adenocarcinoma and large cell carcinoma. Incidence among women increased overall (APC: 1.6, 95% CI: 1.1; 2.0) and in all age groups and histological types, except small cell carcinoma. Age-standardized incidence rate (world) per 100,000 was 54.2 in men and 12.9 in women in 2014. Changes in mortality closely followed those in incidence. According to our predictions, the age-standardized incidence and mortality rates will continue to decrease in men and reach a plateau in women. Conclusions: The study revealed divergent LC trends by gender, age and histological type, which were generally consistent with main international findings. Growing public awareness and stricter tobacco control have stimulated overall favorable changes in men, but not yet in women. Large increase in incidence was observed for adenocarcinoma, which in men showed a trend opposite to the overall decline. LC will remain a serious public health issue in Estonia due to a high number of cases during the next decades, related to aging population, and previous and current smoking patterns. National tobacco control policy in Estonia should prioritize preventing smoking initiation and promoting smoking cessation, particularly among women.
引用
收藏
页数:10
相关论文
共 36 条
  • [1] Aareleid T, 1994, Eur J Cancer Prev, V3, P419, DOI 10.1097/00008469-199409000-00006
  • [2] [Anonymous], EL NIC DEL SYST EL N
  • [3] Lung cancer mortality in European women: Trends and predictions
    Bosetti, Cristina
    Malvezzi, Matteo
    Rosso, Tiziana
    Bertuccio, Paola
    Gallus, Silvano
    Chatenoud, Liliane
    Levi, Fabio
    Negri, Eva
    La Vecchia, Carlo
    [J]. LUNG CANCER, 2012, 78 (03) : 171 - 178
  • [4] Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time
    Brenner, Hermann
    Castro, Felipe A.
    Eberle, Andrea
    Emrich, Katharina
    Holleczek, Bernd
    Katalinic, Alexander
    Jansen, Lina
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 52 : 102 - 108
  • [5] Has the lung cancer risk from smoking increased over the last fifty years?
    Burns, David M.
    Anderson, Christy M.
    Gray, Nigel
    [J]. CANCER CAUSES & CONTROL, 2011, 22 (03) : 389 - 397
  • [6] The increasing incidence of lung adenocarcinoma: Reality or artefact? A review of the epidemiology of lung adenocarcinoma
    Charloux, A
    Quoix, E
    Wolkove, N
    Small, D
    Pauli, G
    Kreisman, H
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (01) : 14 - 23
  • [7] Engholm G., 2016, NORDCAN: Cancer Incidence, Mortality
  • [8] Estonian Institute of Economic Research, 2015, YB
  • [9] Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
    Ferlay, J.
    Steliarova-Foucher, E.
    Lortet-Tieulent, J.
    Rosso, S.
    Coebergh, J. W. W.
    Comber, H.
    Forman, D.
    Bray, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1374 - 1403
  • [10] Ferlay J., 2013, GLOBOCAN 2012 CANC I